Colchicine ameliorates the chronic inflammatory state in patients with chronic rheumatic valvular heart disease: a pilot study

[1] Manyemba J(2003)Intramuscular Penicillinis more effective than oral penicillin in secondary prevention of rheumatic fever,a systematic review S AfrMed J 93 212-218

[2] Mayosi BM(2007)Rheumatic fever and rheumatic heart disease: genetics and pathogenesis Scand J Immunol 66 199-207

[3] Guilherme L(2005)Contribution of selected serum inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class J Heart Valve Dis 14 251-256

[4] Ramasawmy R(2002)Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation Eur J Heart Fail 4 593-595

[5] Kalil J(2006)Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP) Int J Cardiol 109 275-276

[6] Davutoglu V(2019)Circulating cytokines predict severity of rheumatic heart disease Int J Cardiol 289 107-109

[7] Celik A(2014)Does a chronic inflammatory state have a role in the development of mitral restenosis after balloon mitral valvuloplasty? Int J Cardiol 172 PE417-PE418

[8] Aksoy M(2015)The lectin pathway of complement and rheumatic heart disease Front Pediatr 2 148-162

[9] Gölbasi Z(2018)MBL2 gene polymorphism rs1800450 and rheumatic fever with and without rheumatic heart disease: an Egyptian pilot study Pediatr Rheumatol 16 16-24

[10] Uçar Ö(2013)A study on the association of TNF-α-308, IL-6-174, IL-10-1082 and IL-1RaVNTR gene polymorphisms with rheumatic heart disease in Pakistani patients Cytokine 61 527-531

[1] Manyemba J(2003)Intramuscular Penicillinis more effective than oral penicillin in secondary prevention of rheumatic fever,a systematic review S AfrMed J 93 212-218

[2] Mayosi BM(2007)Rheumatic fever and rheumatic heart disease: genetics and pathogenesis Scand J Immunol 66 199-207

[3] Guilherme L(2005)Contribution of selected serum inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class J Heart Valve Dis 14 251-256

[4] Ramasawmy R(2002)Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation Eur J Heart Fail 4 593-595

[5] Kalil J(2006)Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP) Int J Cardiol 109 275-276

[6] Davutoglu V(2019)Circulating cytokines predict severity of rheumatic heart disease Int J Cardiol 289 107-109

[7] Celik A(2014)Does a chronic inflammatory state have a role in the development of mitral restenosis after balloon mitral valvuloplasty? Int J Cardiol 172 PE417-PE418

[8] Aksoy M(2015)The lectin pathway of complement and rheumatic heart disease Front Pediatr 2 148-162

[9] Gölbasi Z(2018)MBL2 gene polymorphism rs1800450 and rheumatic fever with and without rheumatic heart disease: an Egyptian pilot study Pediatr Rheumatol 16 16-24

[10] Uçar Ö(2013)A study on the association of TNF-α-308, IL-6-174, IL-10-1082 and IL-1RaVNTR gene polymorphisms with rheumatic heart disease in Pakistani patients Cytokine 61 527-531